According to clinician ratings, CD40 ligand deficiency is the ‘most severe’ of the PAD disorders in this study, while XLA, CVID, other PAD, and post-BMT PAD are rated as intermediate, and THI is significantly milder. The gene discussed is CD40LG; the disease is hyperinsulinemic hypoglycemia, familial, 4.